Newborn screening, clinical characteristics and genetic variant analysis of Glutaric acidemia type I in Henan Province.
10.3760/cma.j.cn511374-20240308-00161
- Author:
Xinyun ZHU
1
,
2
;
Dehua ZHAO
;
Yizhuo XU
;
Jie ZHANG
;
Xiaole LI
;
Suna LIU
;
Min NI
;
Yihui REN
;
Chong ZHANG
;
Yaqing GUO
;
Junqi LI
;
Shubo LYU
;
Chenlu JIA
;
Ying SHI
Author Information
1. Department of Neonatal Screening, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China. syybr@
2. com.
- Publication Type:Journal Article
- MeSH:
Humans;
Amino Acid Metabolism, Inborn Errors/epidemiology*;
Glutaryl-CoA Dehydrogenase/chemistry*;
Infant, Newborn;
Female;
Neonatal Screening/methods*;
Male;
Brain Diseases, Metabolic/epidemiology*;
China/epidemiology*;
Retrospective Studies;
Mutation;
Genetic Variation;
Glutarates
- From:
Chinese Journal of Medical Genetics
2025;42(6):641-647
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the incidence, clinical features, genetic variant characteristics and prognosis of Glutaric acidemia type I (GA1) among neonates from Henan Province.
METHODS:A total of 814 625 neonates undergoing screening for inherited metabolic diseases by tandem mass spectrometry (MS/MS) at the Third Affiliated Hospital of Zhengzhou University from January 2016 to December 2022 were selected as the study subjects. A retrospective method was adopted to collect the clinical data of the patients. Whole exome sequencing was carried out to detect GCDH gene variants in individuals with positive results by GA1 newborn screening, and Sanger sequencing was used to verify the candidate variants. Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG), the pathogenicity of candidate variants was rated. This study was approved by the Medical Ethics Committee of the Hospital (Ethics Number: 2019 Medical Ethics Review No. 67).
RESULTS:Eight cases of GA1 were diagnosed among the 814 625 neonates. Blood glutaryl carnitine (C5DC) and urine glutaric acid (GA) levels of the 8 children were higher than the normal reference values. In total 12 variants were detected, all of which were missense variants. c.1064G>A (p.Arg355His) was the most common one, accounting for 21.4% (3/14). Three GCDH gene variants, including 1297G>C (p.Ala433Pro), c.467G>A (p.Gly156Asp) and c.1125T>G (p.Cys375Trp), were previously unreported. REVEL software analysis predicted that all of the three variants were harmful. 3D protein structure modeling indicated that the three variants may cause amino acid residue alterations, and c.1297G>C (p.Ala433Pro) and c.1125T>G (p.Cys375Trp) may result in increase in hydrogen bonds and affect the function of GCDH protein. By December 2023, one of the eight children had deceased, and another child had severe clinical symptoms with poor prognosis. Six children had a good prognosis, of which two had mild motor development delay and four had normal development without clinical symptoms.
CONCLUSION:The incidence of GA1 in newborns screened by MS/MS in Henan Province is 1/101 828, and the carrier rate of pathogenic GCDH variants is 1/160. The c.1064G>A (p.Arg355His) may be the hotspot variant of the GCDH gene among children with GA1 in Henan. Discovery of the three novel variants has enriched the mutational spectrum of the GCDH gene and provide a basis for the early diagnosis, treatment, prognosis and genetic counseling of this disease.
